nach oben

Social Psychiatry and Psychiatric Epidemiology

Erschienen in:

01.09.2007 | ORIGINAL PAPER

Current somatoform disorders in Norway: prevalence, risk factors and comorbidity with anxiety, depression and musculoskeletal disorders

verfasst von: Kari Ann Leiknes, MD, MHA, Arnstein Finset, PhD, Torbjørn Moum, PhD, Inger Sandanger, MD, PhD

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 9/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

The future existence of somatoform disorders (SDs) has recently been debated. The objectives of this study were to investigate the prevalence of current SDs (defined as the presence of multisomatoform disorder [MSD] or somatoform disorders not otherwise specified [SDnos], without psychosocial impairment) and severe current SDs (MSD or SDnos with psychosocial impairment) in Norway. Differences in markers of severe current SDs, anxiety/depression and self-reported musculoskeletal disorders were explored. In addition, psychological distress and utilization of healthcare in subclasses (defined according to comorbidity with anxiety, depression and musculoskeletal disorders) of severe current SDs were examined.

Methods

We interviewed 1,247 respondents using the Composite International Diagnostic Interview (CIDI) in the Oslo–Lofoten general population survey in 2000–2001. Six-month prevalence rates (%) and 95% confidence intervals (CIs) for current SDs were investigated by gender and age. Risk factors of disorders, psychological distress, healthcare utilization and use of medication were explored using logistic regression analyses.

Results

The overall prevalence rate for severe current SDs was 10.2%. When psychosocial impairment was excluded as a criterion, the rate increased to 24.6%. Anxiety was strongly correlated with severe current SDs. Comorbidity of severe current SDs with anxiety/depression was 45%, and with musculoskeletal disorders, 43%. Analysis of healthcare utilization and use of medication showed that the presence of a comorbid psychiatric condition was more important than the presence of somatoform disorders alone. Conclusion Somatoform symptoms alone (with no psychiatric comorbidity) should not be considered a psychiatric disorder.

Nur mit Berechtigung zugänglich

American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn., Revised. American Psychiatric Association, Washington, DC

American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC

American Psychiatric Association (1995) Diagnostic and statistical manual of mental disorders, 4th edn., primary care version. American Psychiatric Association, Washington, DC

Barsky AJ, Orav EJ, Bates DW (2005) Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 62:903–910PubMedCrossRef

Barsky AJ, Peekna HM, Borus JF (2001) Somatic symptom reporting in women and men. J Gen Intern Med 16:266–275PubMedCrossRef

Creed F (2006) Can DSM-V facilitate productive research into the somatoform disorders? J Psychosom Res 60:331–334PubMedCrossRef

Creed F, Barsky A (2004) A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res 56:391–408PubMedCrossRef

Duddu V, Isaac MK, Chaturvedi SK (2006) Somatization, somatosensory amplification, attribution styles and illness behaviour: a review. Int Rev Psychiatry 18:25–33PubMedCrossRef

Epstein RM, Quill TE, McWhinney IR (1999) Somatization reconsidered: incorporating the patient’s experience of illness. Arch Intern Med 159:215–222PubMedCrossRef

10.

Fink P (1992) The use of hospitalizations by persistent somatizing patients. Psychol Med 22:173–180PubMedCrossRef

11.

Fink P, Sorensen L, Engberg M, Holm M, Munk-Jorgensen P (1999) Somatization in primary care. Prevalence, health care utilization, and general practitioner recognition. Psychosomatics 40:330–338PubMed

12.

Hiller W (2006) Don’t change a winning horse. J Psychosom Res 60:345–347PubMedCrossRef

13.

Hiller W, Fichter MM (2004) High utilizers of medical care: a crucial subgroup among somatizing patients. J Psychosom Res 56:437–443PubMedCrossRef

14.

Hiller W, Rief W (2005) Why DSM-III was right to introduce the concept of somatoform disorders. Psychosomatics 46:105–108PubMedCrossRef

15.

Hiller W, Rief W, Brahler E (2006) Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc Psychiatry Psychiatr Epidemiol 41:704–712PubMedCrossRef

16.

Ihlebaek C, Eriksen HR, Ursin H (2002) Prevalence of subjective health complaints (SHC) in Norway. Scand J Public Health 30:20–29PubMedCrossRef

17.

Kendell R, Jablenski A (2003) Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 160:4–12PubMedCrossRef

18.

Kringlen E, Torgersen S, Cramer V (2001) A Norwegian psychiatric epidemiological study. Am J Psychiatry 158:1091–1098PubMedCrossRef

19.

Kringlen E, Torgersen S, Cramer V (2006) Mental illness in a rural area: a Norwegian psychiatric epidemiological study. Soc Psychiatry Psychiatr Epidemiol 41:713–719PubMedCrossRef

20.

Kroenke K (2006) Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions. J Psychosom Res 60:335–339PubMedCrossRef

21.

Kroenke K, Spitzer RL, deGruy FV III, Hahn SR, Linzer M, Williams JB, Brody D, Davies M (1997) Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry 54:352–358PubMed

22.

Kroenke K, Spitzer RL, deGruy FV III, Swindle R (1998) A symptom checklist to screen for somatoform disorders in primary care. Psychosomatics 39:263–272PubMed

23.

Leiknes KA, Finset A, Moum T, Sandanger I (2006) Methodological issues concerning lifetime medically unexplained and medically explained symptoms of the Composite International Diagnostic Interview: a prospective 11-year follow-up study. J Psychosom Res 61:169–179PubMedCrossRef

24.

Leiknes KA, Finset A, Moum T, Sandanger I (2006) Overlap, comorbidity and stability of somatoform disorders, and the use of current versus lifetime criteria. Psychosomatics (in press)

25.

Leiknes KA, Finset A, Moum T, Sandanger I (2007) Course and predictors of medically unexplained pain symptoms in the general population. J Psychosom Res 62:119–128PubMedCrossRef

26.

Mayou R, Kirmayer LJ, Simon G, Kroenke K, Sharpe M (2005) Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry 162:847–855PubMedCrossRef

27.

Rief W, Henningsen P, Hiller W (2006) Classification of somatoform disorders. Am J Psychiatry 163:746–747PubMedCrossRef

28.

Rief W, Hiller W (1999) Toward empirically based criteria for the classification of somatoform disorders. J Psychosom Res 46:507–518PubMedCrossRef

29.

Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A, Jablenski A, Pickens R, Regier DA (1988) The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45:1069–1077PubMed

30.

Sandanger I (1993) The Composite International Diagnostic Interview for psychiatric diagnoses as an expounding instrument in the Norwegian Community Diagnosis Project: mental health and physical illness. Int J Methods Psychiatr Res 3:137–141

31.

Sandanger I, Moum T, Ingebrigtsen G, Dalgard OS, Sorensen T, Bruusgaard D (1998) Concordance between symptom screening and diagnostic procedure: the Hopkins Symptom Checklist-25 and the Composite International Diagnostic Interview I. Soc Psychiatry Psychiatr Epidemiol 33:345–354PubMedCrossRef

32.

Sandanger I, Moum T, Ingebrigtsen G, Sorensen T, Dalgard OS, Bruusgaard D (1999) The meaning and significance of caseness: the Hopkins Symptom Checklist-25 and the Composite International Diagnostic Interview. II. Soc Psychiatry Psychiatr Epidemiol 34:53–59PubMedCrossRef

33.

Sandanger I, Nygård JF, Brage S, Tellnes G (2000) Relation between health problems and sickness absence: gender and age differences–a comparison of low-back pain, psychiatric disorders, and injuries. Scand J Public Health 28:244–252PubMedCrossRef

34.

Sandanger I, Nygård JF, Ingebrigtsen G, Sorensen T, Dalgard OS (1999) Prevalence, incidence and age at onset of psychiatric disorders in Norway. Soc Psychiatry Psychiatr Epidemiol 34:570–579PubMedCrossRef

35.

Sandanger I, Nygård JF, Sorensen T, Dalgard OS (2007) Return of depressed men: changes in distribution of depression and symptom cases in Norway between 1990 and 2001. J Affect Disord 100:153–162

36.

Sandanger I, Nygård JF, Sorensen T, Moum T (2004) Is women’s mental health more susceptible than men’s to the influence of surrounding stress? Soc Psychiatry Psychiatr Epidemiol 39:177–184PubMedCrossRef

37.

Sharpe M, Bass C (1992) Pathophysiological mechanisms in somatization. Int Rev Psychiatry 4:81–97

38.

Sharpe M, Mayou R, Walker J (2006) Bodily symptoms: new approaches to classification. J Psychosom Res 60:353–356PubMedCrossRef

39.

Simon GE, Gureje O (1999) Stability of somatization disorder and somatization symptoms among primary care patients. Arch Gen Psychiatry 56:90–95PubMedCrossRef

40.

Smith RC, Gardiner JC (2006) Administrative database screening to identify somatizing patients. Med Care 44:799–802PubMedCrossRef

41.

Smith RC, Gardiner JC, Armatti S, Johnson M, Lyles JS, Given CW, Lein C, Given B, Goddeeris J, Korban E, Haddad R, Kanj M (2001) Screening for high utilizing somatizing patients using a prediction rule derived from the management information system of an HMO: a preliminary study. Med Care 39:968–978PubMedCrossRef

42.

Starcevic V (2006) Somatoform disorders and DSM-V: conceptual and political issues in the debate. Psychosomatics 47:277–281PubMedCrossRef

43.

Sykes R (2006) Somatoform disorders in DSM-IV: mental or physical disorders? J Psychosom Res 60:341–344PubMedCrossRef

44.

Wessely S, Nimnuan C, Sharpe M (1999) Functional somatic syndromes: one or many? Lancet 354:936–939PubMedCrossRef

45.

Wise TN, Birket-Smith M (2002) The somatoform disorders for DSM-V: the need for changes in process and content. Psychosomatics 43:437–440PubMedCrossRef

46.

Wittchen HU, Jacobi F (2005) Size and burden of mental disorders in Europe–a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 15:357–376PubMedCrossRef

47.

Wittchen HU, Lachner G, Wunderlich U, Pfister H (1998) Test–retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 33:568–578PubMedCrossRef

48.

World Health Organization (1978) Mental disorders: glossary and guide to their classification in accordance with the ninth revision of the international classification of diseases. WHO, Geneva, New York

49.

World Health Organization (1993) The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research. WHO, Geneva

Titel: Current somatoform disorders in Norway: prevalence, risk factors and comorbidity with anxiety, depression and musculoskeletal disorders
verfasst von: Kari Ann Leiknes, MD, MHA
Arnstein Finset, PhD
Torbjørn Moum, PhD
Inger Sandanger, MD, PhD
Publikationsdatum: 01.09.2007
Verlag: D. Steinkopff-Verlag
Erschienen in: Social Psychiatry and Psychiatric Epidemiology / Ausgabe 9/2007
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI: https://doi.org/10.1007/s00127-007-0218-8

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2007

Who is treated, and how, for depression?

The mental health status of Chinese rural–urban migrant workers

The physical and social associations of common mental disorder in a tribal population in South India

Perception of the public towards the mentally ill in developed Asian country